Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovaries are defined by having 12 or more small follicles in each ovary and are found in up to 33% of women, while Polycystic Ovary Syndrome (PCOS) is the most common hormone disorder in women of reproductive age, potentially increasing risk of obesity, diabetes, and heart diseases.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

Finasteride doesn't change polycystic ovary size or cyst number, suggesting testosterone's role in their appearance.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Kashmiri women with PCOS have more Bifidobacterium in their gut.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

More research is needed to understand the long-term benefits of insulin-sensitizing drugs for treating adolescents with PCOS.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Classical PCOS types A and B are most common and linked to higher health risks.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Polycystic ovary syndrome causes chronic inflammation affecting all body systems, but proper nutrition, exercise, and supplements can improve the condition.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Laser hair removal can be safe and effective for dark-skinned individuals with the right laser settings.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.